摘要
目的观察喘可治雾化吸入治疗支气管哮喘的疗效。方法选择支气管哮喘患者60例,随机分为治疗组和对照组各30例。治疗组在常规抗感染止咳的基础上使用喘可治加全乐宁雾化吸入,每日2次;对照组在常规抗感染止咳的基础上使用普米克令舒加全乐宁雾化吸入,每日2次。两组疗程均为1周,观察治疗前后咳嗽、喘息、肺功能改善情况、住院天数及6个月内支气管哮喘发作次数。结果治疗组患者临床症状、肺功能改善及住院天数与对照组无明显差异,但治疗组6个月内支气管哮喘发作次数明显少于对照组,具有统计学意义(P<0.01)。结论喘可治雾化吸入治疗支气管哮喘效果明显,同时有增强呼吸道免疫力、减少支气管哮喘发作次数的作用,值得临床推广使用。
Objective To observe the clinical effects of aerosol inhalation of Chuankezhi in treating bronchial asthma. Methods There were 60 patients with bronchial asthma. We divided them randomly into two groups:treatment groupand control group 30 cases in each. Thirty cases were treated by aerosol inhalation of Chuankezhi and Ventolin Respirator Solution plus routine therapy in treatment group and other 30 cases were treated by Pulmicort Respules and Ventolin Respirator Solution plus routine therapy in control group,twence every day for 7 days . The cough, asthma, pulmonary function, days of hospitalization and 6-manth frequency of bronchial asthma were observed before and after treatment. Results the clinical symptoms,pulmonary function improved,days of hospitalization were similar in two groups with there were no significant difference, but the 6-month frequency of bronchial asthma was lower in treatment group than in control group with a significant difference(P〈0.01). Conclusion Aerosol inhalation of "Chuankezhi"is quite effective for bronchial asthma. It can also strengthen immunity of respiratory tract and reduce the frequency of bronchial asthma Aerosol inhalation of "Chuankezhi"is worth using widely in the clinical treatment.
出处
《中国现代医生》
2011年第10期146-147,160,共3页
China Modern Doctor
关键词
支气管哮喘
喘可治
普米克令舒
雾化吸入
Bronchial asthma
Chuankezhi
Pulmicort respules
Aerosol inhalation